Cagrilintide dosing schedule
Human schedule
Cagrilintide (an amylin analog) is administered subcutaneously once weekly with gradual dose escalation in studies. The table below is a generalized reference from published clinical protocols.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Weeks 1–4 | 0.25 mg weekly SubQ | Starting dose |
| Weeks 5–12 | 0.5 → 1.0 mg weekly | Increase every 4 weeks |
| Weeks 13–16 | 1.7 mg weekly | Increase if needed |
| From week 17 | 2.4 mg weekly | Maximum in this schedule |